Lallemand Health Solutions, a lab to shelf manufacturer of probiotic solutions, is proud to be a sponsor and to present at Pharmabiotics 2019. The event takes place 13-14 March at the New Cap Event Center in Paris (France) and focuses on the latest scientific advancements, regulatory information, and live bio therapeutics. We invite you to come by our booth to learn how working with a research-driven, vertically integrated manufacturer can provide the custom or ready-to-market formulation you need.
Dr. Tompkins presentation ‘A Comprehensive Review of a Pharmabiotic Composition in the Management of Irritable Bowel Syndrome in a Chinese Population’ is a systematic review and meta-analysis of clinical studies conducted in China between 2008 and 2018 using the products Medilac-S (adult) and Medilac-Vita (children) also known as IBacilluS+ (Enterococcus faecium R0026and Bacillus subtilis R0179)1. These products were used in different applications including the management of symptoms of Irritable Bowel Syndrome (IBS). In a systematic review of the literature, more than 100 clinical studies have been identified that described a positive outcome, in terms of clinical efficacy in patients with IBS using these formulations. Dr Tompkins presentation will focus on the strength of the clinical evidence as well as make recommendations of the appropriate dose, duration of treatment, age group and the realistic expectations of improvement for the three different types and symptoms of IBS.
Our team of probiotic experts are keen to present our newest product ComboCap®’Biotic, the world’s first side-by-side, dual-chamber, wet-and-dry capsule with a moveable membrane that provides an unlimited range of probiotic formula possibilities. They are also eager to discuss potential partnership and licensing opportunities as well as share the latest research and innovation in the Brain-Gut Axis, Gut Health, Immunity, Women’s Health, Oral Health, and Sport probiotic categories.
We are looking forward to meeting you in Paris.